Favipiravir in patients hospitalised with COVID-19 (PIONEER trial): a multicentre, open-label, phase 3, randomised controlled trial of early intervention versus standard care

Pallav L. Shah(Guy's and St Thomas' NHS Foundation Trust), Dilys Lai, Christopher M. Orton(University of Hull), Dexter Wiseman(University of Hull), Brenda Crabtree‐Ramírez(Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán), Marta Boffito(Chelsea and Westminster Hospital NHS Foundation Trust), Francesca Conway(University of Hull), Lester Macabodbod, Cielito Caneja, Carmen Winpenny, Breno Santos(Hospital Nossa Senhora da Conceição), Simon Connolly, Rhian Bull, Carrie Fung, Beatriz Grinsztejn(Fundação Oswaldo Cruz), Patricia Costa, Michael Pelly(University of Hull), Doris Daby, Kribashnie Nundlall, Colby Adamson, Justin Garner(Royal Brompton Hospital), Sajjida Jaffer, Pankaj Bhavsar(University of Hull), Marie‐Louise Svensson, Anda Samson(University of Hull), Craig Leaper(University of Hull), Andrew I. Ritchie(University of Hull), Amrinder Sayan, Anton Pozniak, Alexandra Schoolmeesters, Laura Gomes de Almeida Martins, Gavin C. Donaldson(Boehringer Ingelheim (Egypt)), Maria Eleanor Flores(University of Hull), Bavithra Vijayakumar(Manchester University NHS Foundation Trust), Serge Fedele, Anand Tana(Royal Brompton Hospital), Damon Foster, Rosalie Houseman, Maria P D Riberio(University of Hull), Sandra Wagner Cardoso(Instituto Evandro Chagas), Samuel Pepper, Carina Bautista, Jamie Carungcong, James Tonkin(Royal Brompton Hospital), Mark R Johnson(University of Hull), Shameera Maheswaran, Pardina Samson-Fessale, Bobby Mann(University of Hull), Andrea Cartier
The Lancet Respiratory Medicine
December 14, 2022
Cited by 58


Related Papers